BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000296 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
144,883
Total Value
$0.00
P&L
+inf% (+$9,930,280.82)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (Right to Buy) | Derivative | Mar 17, 2026 | Grant/Award | 40,570 | $0.00 | $0.00 | 40,570 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Mar 17, 2026 | Grant/Award | 104,313 | $0.00 | $0.00 | 104,313 | Direct | โ | View Details |